Correlation Between Catalyst Pharmaceuticals and IHH Healthcare

Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and IHH Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and IHH Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Catalyst Pharmaceuticals and IHH Healthcare Berhad, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and IHH Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of IHH Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and IHH Healthcare.

Diversification Opportunities for Catalyst Pharmaceuticals and IHH Healthcare

0.0

Correlation Coefficient

Catalyst Pharmaceuticals  IHH Healthcare

Pay attention - limited upside

The 3 months correlation between Catalyst and IHH is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and IHH Healthcare Berhad in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IHH Healthcare Berhad and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with IHH Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IHH Healthcare Berhad has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and IHH Healthcare go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and IHH Healthcare

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 1.9 times more return on investment than IHH Healthcare. However, Catalyst Pharmaceuticals is 1.9 times more volatile than IHH Healthcare Berhad. It trades about 0.02 of its potential returns per unit of risk. IHH Healthcare Berhad is currently generating about -0.01 per unit of risk. If you would invest  1,902  in Catalyst Pharmaceuticals on September 29, 2024 and sell it today you would earn a total of  245.00  from holding Catalyst Pharmaceuticals or generate 12.88% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	68.35%
Values	Daily Returns

Catalyst Pharmaceuticals  vs.  IHH Healthcare Berhad

Catalyst Pharmaceuticals

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Catalyst Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

IHH Healthcare Berhad

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days IHH Healthcare Berhad has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, IHH Healthcare is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Catalyst Pharmaceuticals and IHH Healthcare

The main advantage of trading using opposite Catalyst Pharmaceuticals and IHH Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, IHH Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IHH Healthcare will offset losses from the drop in IHH Healthcare's long position.

The idea behind Catalyst Pharmaceuticals and IHH Healthcare Berhad pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.